CLINICAL_TRIALS
trial_result
· 2021-03-18
Clinical Trial Update: Safety and Immunogenicity of V114 in Healthy Adults (V114-019/PNEU-AGE) [Phase 3]
Summary
Phase 3 trial update reporting safety and immunogenicity data for V114 in healthy adults (Pneumococcal infections).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Pneumococcal Infections | Phase 3 | Status: COMPLETED | Results posted: 2021-03-18